Breast Cancer - Herceptin and HER2

One of the biggest and most exciting advances inHerceptin is the wave of the future.
recent history in the fight against breast cancer isSo how does a breast cancer patient receive
a drug called Herceptin. (Trastuzumab) The drugherceptin? Their cancer must show that it
has shown to be very successful against certainover-expresses the HER2 protein. This is
types of advanced breast cancers. Some moredetermined by having a pathologist test the
recent clinical trials have shown that herceptincancerous cells that were removed from the
may also be successful against certain types ofbreast during surgery. He or she will stain the
earlier stage breast cancers. Herceptin has beentissue with a solution that will highlight any instance
approved for use in 1998 by the FDA.of overproduction of HER2. If a patient has the
By certain types of cancers we are referring toHER2 over-expression present, they are
those that over-express a protein that is calledconsidered to be HER2 positive and therefore it
HER2. HER2 stands for human epidermal growthcould be possible to treat their cancer with
factor receptor 2. HER2 can be found on theherceptin if needed.
surface of cells and it is what is responsible forHerceptin is not for everyone. It is approved for
keeping the growth of the cell in check. Whentreatment of women with advanced cancer in
HER2 malfunctions and begins to produce toocombination with the chemotherapy drug,
much of itself due to a mutation it can cause thepaclitaxel. There are side effects associated with
cells to produce too much of themselves toothe drug and one of those includes cardiotoxicity
quickly. This in turn can make cancers behave in awhich can cause serious heart problems in
much more aggressive manner. The HER2patients. Therefore heart monitoring before,
over-expression is a factor in 20% to 30% ofduring and after treatment is crucial. Less serious
breast cancer occurrences.side effects include fever, chills, increased cough,
The official scientific big word description ofdiarrhea and weakness. If herceptin is given with
Herceptin is that it is a monoclonal antibody,chemotherapy, nausea is possible. Other
engineered via biotechnology. The way it works ismoderately severe side effects include loss of
by attaching itself to any cells that arewhite blood cells and anemia.
overproducing the HER2 protein. It attacks theA diagnosis of breast cancer can be a frightening
protein receptors which then slows the growth ofthing, especially if you are in the percentage of
the cells down. It targets the HER2 protein aspatients that have the more aggressive HER2
opposed to traditional types of treatment whichcancer. Knowing that there is another treatment
tend to destroy all fast growing cells in their path,that has been proven to be effective against
healthy or cancerous. This is a big improvementthose types of cancers brings increased hope of
over certain types of chemotherapy. Thesurvival to these women and men.
development of targeted treatments like